Tomonori Waku

Title: Tomonori Waku: Innovator in Collagen Crosslinking Agents

Introduction

Tomonori Waku is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biocompatible materials, particularly in the development of collagen crosslinking agents. His innovative work addresses critical issues related to biocompatibility and toxicity in medical applications.

Latest Patents

Waku holds a patent for a noncovalent collagen crosslinking agent. This invention provides a collagen crosslinking agent that is superior in biocompatibility and free from damage caused by UV irradiation. Additionally, it addresses the problems of toxicity associated with residual monomers or unreacted functional groups. The noncovalent collagen crosslinking agent comprises a spacer of a polyvalent alcohol with two or more OH groups at the terminals and arms of collagen peptides, which are formed from repetitions of three amino acids.

Career Highlights

Throughout his career, Tomonori Waku has worked with prestigious institutions, including Osaka University and Tohoku University. His research has focused on enhancing the properties of collagen for various applications, particularly in the biomedical field.

Collaborations

Waku has collaborated with notable colleagues, including Mitsuru Akashi and Kohji Nishida. Their joint efforts have contributed to advancements in the understanding and application of collagen crosslinking agents.

Conclusion

Tomonori Waku's innovative work in developing biocompatible collagen crosslinking agents showcases his commitment to improving medical materials. His contributions are significant in addressing the challenges of toxicity and biocompatibility in biomedical applications.